Selection of patients for liver transplantation and allocation of donated livers in the UK

Gut

Volumn 57, Issue 2, 2008, Pages 252-257

  Neuberger, James ^a   Gimson, A ^b   Davies, M ^c   Akyol, M ^d   O'Grady, J ^e   Burroughs, A ^f   Hudson, M ^g  

^a QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f ROYAL FREE HOSPITAL   (United Kingdom)

^g FREEMAN HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHRONIC LIVER DISEASE; DEATH; HOSPITAL ADMISSION; HUMAN; LIVER FAILURE; LIVER TRANSPLANTATION; ORGAN DONOR; PATIENT SELECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK; UNITED KINGDOM;

GREAT BRITAIN; HEALTH CARE RATIONING; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; PATIENT SELECTION; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 38549149260     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2007.131730     Document Type: Article

References (32)

1. Dawwas MF, Gimson AE, Lewsey JD, et al. Survival after liver transplantation in the United Kingdom compared with the United States. Gut 2007;56:1606-13. Published Online First: 13 March 2007 doi:10.1136/gut.2006.111369.
2. Pomfret EA, Fryer JP, Sima CS, et al. Liver and intestine transplantation in the United States 1996-2005. Am J Transplant 2007;1:1376-89.
3. van der Meulen JH, Lewsey JD, Dawwas MF, et al. UK and Ireland Liver Transplant Audit. Adult orthotopic liver transplantation in the United Kingdom and Ireland between 1994 and 2005. Transplantation 2007;84:572-9.
4. Neuberger J, James O. Guidelines for selection of patients for liver transplantation in the era of donor shortage. Lancet 1999;354:1636-9.
5. O'Grady J, Alexander GJ, Hayllar KM, et al. Early prognostic indicators of prognosis in fulminant hepatic failure. Gastroenterology 1989;97:439-45.
6. MacQuillan GC, Seyam MS, Neuberger J, et al. Blood lactate but not serum phosphate levels can predict patient outcome in fulminant hepatic failure. Liver Transplant 2005;11:1073-9.
7. Bathgate A, UK Liver Transplant Units. Recommendations for alcohol-related liver disease. Lancet 2006;367:2045-6.
8. Barber KM, Pioli S, Blackwell JE, et al. Development of a UK score for patients with end-stage liver disease. Hepatology 2007;46:510A.
9. Hendrickse A, Azam F, Mandell MS. Hepatopulmonary syndrome and portopulmonary hypertension. Curr Treat Options Cardiovasc Med 2007;9:127-36.
10. Burns PN, Wilson SR. Focal liver masses: enhancement patterns on contrast enhanced images - concordance of US scans with CT scans and MR images. Radiology 2007;242:162-74.
11. Yao FY, Ferrell L, Bass NM, et al. Liver transplantation for hepatocellular carcinoma: comparison of the proposed ECSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002;8:765-74.
12. Decaens T, Roudot-Thoraval F, Hadni-Bresson S, et al. Impact of the UCSF criteria according to pre- and post-OLT tumour features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl 2006;12:1761-9.
13. Sotiropoulos GC, Molmenti EP, Omar OS, et al. Liver transplantation for hepatocellular carcinoma in patients beyond the Milan criteria but within the UCSF criteria. Eur J Med Res 2006;11:467- 70.
14. Koehl GE, Andrassy J, Guba M, et al. Rapamycin protects allografts from rejection while simultaneously attacking tumours in immunosuppressed mice. Transplantation 2004;77:1319-26.
15. Wall WJ. Hepatocellular cancer, transplantation and sirolimus. Liver Transplantation 2004;10:1312-14.
16. Llovet JM, Bruix J. Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolisation improves survival. Hepatology 2003;37:429-42.
17. Heuman DM, Abou-Assi SG, Habib A, et al. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at risk for early death. Hepatology 2004;40:802-10.
18. Cholongitis E, Marelli L, Shusang V, et al. A systematic review of the performance of the model of the end-stage liver disease (MELD) in the setting of liver transplantation. Liver Transplantation 2006;12:1049-61.
19. Newton JL, Bhala N, Burt J, et al. Characterisation of the associations and impact of symptoms in primary biliary cirrhosis using a disease specific quality of life measure. J Hepatol 2206;44:776-83.
20. Merion RM, Schaubel DE, Dykstra DM, et al. The survival benefit of liver transplantation. Am J Transplant 2005;5:307-13.
21. Jacob M, Copley LP, Lewsey JD, et al. Pre-transplant MELD score and post liver transplantation in the UK and Ireland. Liver Transplantation 2004;10:908-10.
22. Burroughs AK, Sabin CA, Rolles K, et al. 3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome. Lancet 2006;367:225-32.
23. Cescon M, Spada M, Colledan M, et al. Feasibility and limits of split liver transplantation from pediatric donors: an Italian multicenter experience. Ann Surg 2006;244:805-14.
24. Feng S, Goodrich NP, Bragg-Gresham JL, et al. Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant 2006;6:783-90.
25. Haydon GH, Hiltunen Y, Lucey MR, et al. Self-organizing maps can determine outcome and match recipients and donors at orthotopic liver transplantation. Transplantation 2005;79:213-8.
26. Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults in the liver transplant waiting list. Liver Transplant Surg 1997;3:628-37.
27. Wiesner RH, McDiarmid SV, Kamath PS, et al. MELD and PELD: application of survival models to liver allocation. Liver Transplantation 2001;7:567-80.
28. Olthoff KM, Brown Jr RS, Delmonico FL, et al. Summary report of a national conference: evolving concepts in liver allocation in the MELD and PELD era. Liver Transplation 2004;10(Suppl 2);A6-22.
29. Chao SD, Roberts JP, Farr M, et al. Short waitlist time does not adversely impact outcome following liver transplantation for hepatocellular carcinoma. Am J Transplant 2007;7:1594-600.
30. de la Mata M, Cuende N, Huet J, et al. Model for end-stage liver disease score-based allocation of donors for liver transplantation: a Spanish multi-center experience. Transplantation 2006;82:1429-35.
31. Onaca N, Mor E. MELD-based allocation scheme for liver transplantation in Israel. Isr Med Assoc J 2006;8:651-2.
32. Teixeira AC, Souza FF, de Assis Mota G, et al. Liver transplantation: expectation with MELD score for liver allocation in Brazil. Acta Cir Bras 2006;21(Suppl 1):12-14.